Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Liver Regeneration

Liver Regeneration

The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...

Tissue Renewal without Stem Cells

Tissue Renewal without Stem Cells

After cellular or tissue damage, the resident stem cells present in the human body can locally repair and regenerate the damaged tissue or organ. However, even though some tissues do not have stem cells, they can repair and regenerate with the help of pre-existing cells. For example, beta cells of the pancreas and hepatocytes of the liver can divide to renew and regenerate the tissue. Here, both cell division and cell death are well regulated by homeostasis.
However, failure of such a system...

Regulation of Hematopoietic Stem Cells

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...

Cirrhosis II: Pathophysiology

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...

Multipotency of Hematopoietic Stem Cells

Multipotency of Hematopoietic Stem Cells

The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...

Stem Cell Therapy for Tissue Regeneration

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Longitudinal Evaluation of Delirium in Liver Transplant Recipients.

Delirium (Bielefeld, Germany)·2025

Same author

Impact of Longitudinal Patterns of Alcohol Use on Mortality in People Who Inject Drugs: A Prospective, Community-based Cohort Study.

Journal of addiction medicine·2025

Same author

Evaluation of Anti-Pseudomonal Versus Non-Pseudomonal Agents for Peri-Operative Antibiotic Prophylaxis in Patients Undergoing Delayed Biliary Reconstruction After Liver Transplantation.

Surgical infections·2025

Same author

Not All Coverage Is Equal: State-Level Medicaid Eligibility Drives Waitlist and Survival Outcomes for Pediatric Non-Citizens.

Pediatric transplantation·2025

Same author

A geospatial analysis of liver transplant centers and alcohol-related liver disease across the United States.

Journal of liver transplantation·2025

Same author

National Trends in Machine Perfusion and Living Donor Liver Transplantation: Complement or Competition?

Transplantation·2025

Same journal

Total Pancreatectomy and Islet Cell Autotransplantation: Does It Have Long Lasting Benefits?

Advances in surgery·2025

Same journal

Clinical Decision-Making for Patients with Chronic Limb-Threatening Ischemia.

Advances in surgery·2025

Same journal

What Is the Role of Irreversible Electroporation for Pancreatic Cancer?

Advances in surgery·2025

Same journal

Airway Foreign Bodies in Children: Old Problem, New Advances.

Advances in surgery·2025

Same journal

Digestive Foreign Bodies in Children: Old Problems, New Complexities.

Advances in surgery·2025

Same journal

Management of Abdominal Wall Mesh Infections.

Advances in surgery·2025

See all related articles

Search research articles

Related Experiment Video

Updated: May 29, 2026

Isolation of CD133+ Liver Stem Cells for Clonal Expansion

Isolation of CD133+ Liver Stem Cells for Clonal Expansion

Published on: October 10, 2011

Stem cells in acute liver failure.

Russell N Wesson¹, Andrew M Cameron

¹Department of Surgery, Johns Hopkins Medical Institutions, 720 Rutland Avenue, Baltimore, MD 21205, USA.

Advances in Surgery

|September 30, 2011

Summary

This summary is machine-generated.

Hematopoietic stem cells (HSCs) show promise for treating acute liver failure. Mobilizing HSCs with drugs like plerixafor could aid liver regeneration and improve patient survival, warranting clinical trials.

More Related Videos

Intrasplenic Transplantation of Hepatocytes After Partial Hepatectomy in NOD.SCID Mice

Intrasplenic Transplantation of Hepatocytes After Partial Hepatectomy in NOD.SCID Mice

Published on: February 10, 2018

Cell Type-specific Gene Expression Profiling in the Mouse Liver

Cell Type-specific Gene Expression Profiling in the Mouse Liver

Published on: September 17, 2019

Related Experiment Videos

Last Updated: May 29, 2026

Isolation of CD133+ Liver Stem Cells for Clonal Expansion

Isolation of CD133+ Liver Stem Cells for Clonal Expansion

Published on: October 10, 2011

Intrasplenic Transplantation of Hepatocytes After Partial Hepatectomy in NOD.SCID Mice

Intrasplenic Transplantation of Hepatocytes After Partial Hepatectomy in NOD.SCID Mice

Published on: February 10, 2018

Cell Type-specific Gene Expression Profiling in the Mouse Liver

Cell Type-specific Gene Expression Profiling in the Mouse Liver

Published on: September 17, 2019

Area of Science:

Regenerative Medicine
Hepatology
Hematology

Background:

Acute liver failure (ALF) presents significant treatment challenges, with high mortality despite transplantation.
Existing therapies are limited by organ shortages and management complications.
Pharmacologic interventions to enhance liver recovery are urgently needed.

Purpose of the Study:

To explore the potential of hematopoietic stem cells (HSCs) in promoting liver regeneration and improving outcomes in acute liver failure.
To investigate the feasibility of using pharmacologic agents to mobilize HSCs for ALF treatment.
To identify the mechanisms and specific cell populations involved in stem cell-mediated liver repair.

Main Methods:

Review of existing evidence from small animal models and human observations regarding HSC participation in liver recovery.
Consideration of pharmacologic agents like plerixafor and G-CSF, known for their stem cell mobilizing properties.
Discussion of potential applications in ALF and other clinical scenarios, such as liver resection.

Main Results:

HSCs may differentiate into hepatocytes or provide supportive paracrine/cellular functions to aid liver repair.
Pharmacologic agents can mobilize HSCs, a strategy successfully used in other patient populations.
Evidence suggests HSC mobilization could accelerate local repair mechanisms in a failing liver.

Conclusions:

Mobilizing HSCs represents a promising therapeutic strategy for acute liver failure.
Further research is needed to clarify the precise mechanisms and cell types involved.
Clinical trials are warranted to assess the efficacy of stem cell mobilization in ALF patients, potentially improving survival and aiding liver remnant function.